VTGN - VistaGen Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
31.55M
Enterprise Value 3
39.07M
Trailing P/E
N/A
Forward P/E 1
-2.15
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
N/A
Enterprise Value/Revenue 3
N/A
Enterprise Value/EBITDA 6
-1.60

Trading Information

Stock Price History

Beta (5Y Monthly) -0.75
52-Week Change 3-50.81%
S&P500 52-Week Change 324.65%
52 Week High 31.8600
52 Week Low 30.2900
50-Day Moving Average 30.7131
200-Day Moving Average 30.7880

Share Statistics

Avg Vol (3 month) 3846.31k
Avg Vol (10 day) 3183.78k
Shares Outstanding 542.62M
Float 38.1M
% Held by Insiders 111.69%
% Held by Institutions 112.37%
Shares Short (Dec 30, 2019) 42.88M
Short Ratio (Dec 30, 2019) 41.96
Short % of Float (Dec 30, 2019) 46.78%
Short % of Shares Outstanding (Dec 30, 2019) 46.66%
Shares Short (prior month Nov 28, 2019) 41.95M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:20
Last Split Date 3Aug 13, 2014

Financial Highlights

Fiscal Year

Fiscal Year Ends Mar 30, 2019
Most Recent Quarter (mrq)Sep 29, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-173.69%
Return on Equity (ttm)-620.78%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -24.38M
Net Income Avi to Common (ttm)-25.68M
Diluted EPS (ttm)-0.6810
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)4.07M
Total Cash Per Share (mrq)0.09
Total Debt (mrq)4.34M
Total Debt/Equity (mrq)590.67
Current Ratio (mrq)1.14
Book Value Per Share (mrq)-0.09

Cash Flow Statement

Operating Cash Flow (ttm)-16.36M
Levered Free Cash Flow (ttm)-9.19M